British Transplant ID, Mycology and Infections in the Immune Compromised Network
Joined January 2022
- Tweets81
- Following189
- Followers517
- Likes8
BRITMIC retweeted
Had a lot of fun recording the @RCPhysicians podcast with @DrRohanMe on...what else..all things fungal infection...
Look out for the podcast on the RCP site soon..
BRITMIC retweeted
🆕 Antifungal TDM toolkit
Download the infographics here: funguseducationhub.org/funga…
BRITMIC retweeted
And on the topic of Cryptococcus..possible new drug in the works
There are few drugs to combat the fungal pathogen Cryptococcus neoformans. Brilacidin, a novel host defense peptide mimetic, may be a promising option—the compound inhibits C. neoformans growth & potentiates the activity of other antifungals. @mbiojournal: asm.social/1XM
ALT BRI potentiates CAS against C. neoformans and C. gattii. (a–c) Checkerboard and cidality assays using XTT. C. neoformans and C. gattii were grown for 48 h in RPMI medium with various combinations of BRI + CAS. (d) BRI + micafungin. (e) BRI + anidulafungin. (f) BRI + AmB. (g) BRI + voriconazole. (h) BRI + fluconazole. (i) BRI +5-FC.
BRITMIC retweeted
Another great Cryptococcus paper..!
On a roll
#FungalFriday
#PLOSPathogens: Population heterogeneity in Cryptococcus neoformans: Impact on pathogenesis dx.plos.org/10.1371/journal.…
BRITMIC retweeted
So it's official
Candida auris had another clade
Clade VI - from Singapore 🇸🇬
Interestingly looks relatively drug susceptible - for now...
thelancet.com/journals/lanmi…
BRITMIC retweeted
Delighted to have been involved in this comprehensive, up to date review of the management of Cryptococcal meningitis
just published in @PracticalNeurol
pn.bmj.com/content/early/202…
Thanks for the talk @DrNeilStone!
Delighted to gave given a @BRITMICNetwork talk on novel antifungal drugs
There are loads of new antifungals coning through!
And they have names like fosmanogepix and ibrexafungerp..
Reminds me of
BRITMIC retweeted
Now for Top Papers papers in transplant ID.
First up @HansHHirsch1 of 🇨🇭who picks a nice paper showing a reduced risk of bacteraemias patients on PJP prophylaxis because CTX is of course a broad spectrum antibiotic!
#ECCMID2024 #escmidglobal2024
BRITMIC retweeted
Top Papers in stem cell transplant infection
Clarisse Machado of 🇧🇷 picks them out
My fave-Infection diagnosis by metagenomics ..its a 🔥 topic
Group from 🇨🇳picked up many more viral and bacterial infections. Fungi - not so much
#eccmid2024 #escmidglobal2024
BRITMIC retweeted
Next in top papers in transplant and one from @TheLancetHaem on regionally specific infections in transplant
Depending on where you are in the 🌍don't forget coccidiomycosis , leishmaniasis , histoplasmosis ..
#eccmid2024 #escmidglobal2024
Top Papers in stem cell transplant infection
Clarisse Machado of 🇧🇷 picks them out
My fave-Infection diagnosis by metagenomics ..its a 🔥 topic
Group from 🇨🇳picked up many more viral and bacterial infections. Fungi - not so much
#eccmid2024 #escmidglobal2024
Looking forward to strong partnerships with @BRITMICNetwork!
Excited to get more involved with The ESCMID Study Group for Infections in Compromised Hosts (ESGICH) and meet in person some of its leaders including @MichaelIsonMD and @maricar_malinis!
#ECCMID2024 #ESCMIDGlobal2024
BRITMIC retweeted
Good for end of day overload - 4 minute flash sessions. Short sharp to the point talks.👍👍👍
Hearing about Candida auris susceptibility testing from Maria Siopi of 🇬🇷where there is unfortunately a LOT of Candida auris ..
🍄🍄🍄😩😩😩
#eccmid2024 #escmidglobal2024
BRITMIC retweeted
Transplant ID it's evolving.
Understanding infections in this setting are crucial to transplant success
#ECCMID2024
#ECCMID Using comprehensive data from every solid organ transplant in Switzerland - able to estimate the burden & cause of infections in these patients. Enterobacteriaceae, enterococcus & resp viruses dominating with low rates of the classic 'opportunistic' pathogens.
BRITMIC retweeted
Social media is filled with disinformation. It can be a dire, dispiriting place.
But I've decided to stick around and not give in to the tsunami of nonsense on here.
If we leave - they win
@ESCMID #ECCMID2024 #ESCMIDGlobal
Interesting discussion on weaponisation of social media from extreme sides. We see it right now about politics & science
#ESCMIDGlobal24
‘Taking yourself out of the equation is not an option. Must stay online and contribute to the narrative.’ Totally agree @kakape @DrNeilStone
BRITMIC retweeted
Interesting discussion on weaponisation of social media from extreme sides. We see it right now about politics & science
#ESCMIDGlobal24
‘Taking yourself out of the equation is not an option. Must stay online and contribute to the narrative.’ Totally agree @kakape @DrNeilStone
In case you‘re already at #ESCMID #ECCMID2024 I‘ll be talking in a session tomorrow on communication during the pandemic with the great @HelenBranswell, @SiouxsieW and @djoudalbaye
BRITMIC retweeted
No surprise that #eccmid2024 #ESCMIDGlobal opens with a focus on antimicrobial resistance (AMR)
This is not only the biggest issue in Infectious Diseases, but for all of us.
Simply one of the biggest threats to humanity- as we face a world without effective antibiotics
Kicking off #ECCMID2024. Session on diagnostics highlighting emergence & evolution of AMR threats worldwide such as NDM @TheLancetInfDis shorturl.at/gtWZ0. Without global diagnostic capacity we will be unable to identify, respond or contain these threats.
BRITMIC retweeted
Scedosporium and lomentospora are two of the nastiest, hardest to treat fungi out there.
@FannyLanternier from 🇫🇷 here updating us at
#eccmid2024 #ESCMIDGlobal @ESCMID @efisg_escmid
BRITMIC retweeted
All set for #eccmid2024 #ESCMIDGlobal, the largest Infectious Diseases and Microbiology conference of the year
I'll be tweeting highlights over the next 4 days - will be following on line initially but will be joining soon in Barcelona!
BRITMIC retweeted
#ECCMID Using comprehensive data from every solid organ transplant in Switzerland - able to estimate the burden & cause of infections in these patients. Enterobacteriaceae, enterococcus & resp viruses dominating with low rates of the classic 'opportunistic' pathogens.